613 related articles for article (PubMed ID: 19793708)
41. High-dose intravenous chelation therapy with deferoxamine.
Cohen A; Mizanin J; Schwartz E
Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
[No Abstract] [Full Text] [Related]
42. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
[TBL] [Abstract][Full Text] [Related]
43. Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
Leitch HA; Vickars LM
Hematology Am Soc Hematol Educ Program; 2009; ():664-72. PubMed ID: 20008252
[TBL] [Abstract][Full Text] [Related]
44. Deferasirox: for iron overload: only a third-line option.
Prescrire Int; 2007 Oct; 16(91):196. PubMed ID: 17929382
[TBL] [Abstract][Full Text] [Related]
45. Early cardiac iron overload in children with transfusion-dependent anemias.
Fernandes JL; Fabron A; Verissimo M
Haematologica; 2009 Dec; 94(12):1776-7. PubMed ID: 19815835
[No Abstract] [Full Text] [Related]
46. Serum ferritin concentrations in transfusion dependent beta-thalassaemia.
George E; Wong HB; George R; Ariffin WA
Singapore Med J; 1994 Feb; 35(1):62-4. PubMed ID: 8009283
[TBL] [Abstract][Full Text] [Related]
47. Iron overload and chelation therapy in myelodysplastic syndromes.
Temraz S; Santini V; Musallam K; Taher A
Crit Rev Oncol Hematol; 2014 Jul; 91(1):64-73. PubMed ID: 24529413
[TBL] [Abstract][Full Text] [Related]
48. Iron overload in β-thalassemia intermedia: an emerging concern.
Musallam KM; Cappellini MD; Taher AT
Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
[TBL] [Abstract][Full Text] [Related]
49. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.
Di Tucci AA; Matta G; Deplano S; Gabbas A; Depau C; Derudas D; Caocci G; Agus A; Angelucci E
Haematologica; 2008 Sep; 93(9):1385-8. PubMed ID: 18603557
[TBL] [Abstract][Full Text] [Related]
50. Management of iron overload in the pediatric patient.
Cohen A
Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185
[TBL] [Abstract][Full Text] [Related]
51. Advances in the use of iron-chelating agents for the treatment of iron overload.
Modell B
Prog Hematol; 1979; 11():267-312. PubMed ID: 392593
[No Abstract] [Full Text] [Related]
52. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
Taher A; Hershko C; Cappellini MD
Br J Haematol; 2009 Dec; 147(5):634-40. PubMed ID: 19681884
[TBL] [Abstract][Full Text] [Related]
53. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
[TBL] [Abstract][Full Text] [Related]
54. [Therapeuetic management of patients with thalassemia major].
Thuret I
Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
[TBL] [Abstract][Full Text] [Related]
55. Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.
Wells RA; Leber B; Buckstein R; Lipton JH; Hasegawa W; Grewal K; Yee K; Olney HJ; Larratt L; Vickars L; Tinmouth A
Leuk Res; 2008 Sep; 32(9):1338-53. PubMed ID: 18405971
[TBL] [Abstract][Full Text] [Related]
56. An instrument assessing satisfaction with iron chelation therapy: Psychometric testing from an open-label clinical trial.
Rofail D; Viala M; Gater A; Abetz-Webb L; Baladi JF; Cappellini MD
Adv Ther; 2010 Aug; 27(8):533-46. PubMed ID: 20652657
[TBL] [Abstract][Full Text] [Related]
57. Iron overload in MDS-pathophysiology, diagnosis, and complications.
Gattermann N; Rachmilewitz EA
Ann Hematol; 2011 Jan; 90(1):1-10. PubMed ID: 20938663
[TBL] [Abstract][Full Text] [Related]
58. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
Musallam KM; Cappellini MD; Wood JC; Taher AT
Blood Rev; 2012 Apr; 26 Suppl 1():S16-9. PubMed ID: 22631036
[TBL] [Abstract][Full Text] [Related]
59. Intensification of chelating-therapy in patients with thalassemia major.
Laws HJ; Göbel U; Christaras A; Janssen G
Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
[TBL] [Abstract][Full Text] [Related]
60. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
